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Factors associated with loss to
follow-up in Tuberculosis treatment
in  the Huambo Province, Angola
Dear  Editor,
Loss  to  follow-up  during  treatment  is  considered  one  of  th
obstacles  in  the  fight  against  tuberculosis  (TB).1 Angola  
among  the  top  thirty  countries  in  the  world  ranked  by  T
burden  with  a  TB  treatment  coverage  of  51%  and  a  succe
rate  of  27%  for  new  cases  and  28%  for  previously  treate
cases.2
The  health  network  of  Huambo  province,  in  addition  t
hospitals,  centres  and  health  posts,  includes  a  sanatoriu
hospital,  eleven  outpatient  clinics  and  an  Anti-Tuberculos
Dispensary  (ATD)  --  responsible  for  the  TB  outpatient  man
gement.
With  the  aim  of  identifying  the  factors  related  to  loss  t
follow-up  in  TB  treatment  in  the  population  of  Huambo  w
designed  a  prospective  and  retrospective  study  in  patien
followed  in  the  ATD  with  a  TB  diagnosis  between  Octobe
2015  and  January  2016  (n  =  353).The  data  collection  was  performed  using  a  questionnaire
developed  for  this  study  and  filled  out  at  monthly  follow-
up  consultations  by  nursing  technicians  and  researchers
e
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in  the  TB  field,  after  receiving  specific  training.  Patien
were  individually  questioned  in  a  closed  environment  on  th
ATD  premises  to  maintain  privacy,  after  clarification  of  th
study  and  informed  consent.  End-of-treatment  results  wer
obtained  from  the  clinical  records  of  the  patients  in  the  en
of  August  2016.  Loss  to  follow-up  was  considered  for  patien
who  started  treatment  but  did  not  complete  it.3
All  statistical  analysis  was  performed  using  R  versio
3.3.2.  A  univariate  and  multivariate  logistic  regression  wa
performed  with  the  response  being  loss  to  follow-up  in  T
treatment.  For  the  multivariate  analysis  the  complete  mod
was  determined  starting  with  a  selection  of  variables  whos
p-value  was  <0.10  in  the  univariate  analysis,  and  using  th
stepwise  regression  method  that  minimizes  the  AIC  (Akaik
Information  Criterion).  The  model  discrimination  ability  wa
given  by  the  area  under  the  ROC  curve.  The  significance  lev
was  set  at  0.05.
The  study  was  authorized  by  the  General  Directorate  o
the  Sanitary  Hospital  of  Huambo,  Angola  and  approved  b
the  Ethics  Committee  of  the  São  João  Hospital  Center  an
the  Faculty  of  Medicine  of  the  University  of  Porto,  Portu
gal.
Of  the  353  patients  who  started  treatment,  309  wer
included  in  the  analysis,  with  no  age  limitation,  both  gen-
ders,  new  cases  as  well  pre-treated  cases.  The  44  patients
excluded  from  the  analysis  consisted  of  42  who  did  not  have
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Univariate  Analysis  Multivariate  Analysis
OR  (  95%  IC) p-value  OR  (  95%  IC)  p-value
Patients  n  207  102
County
Huambo  175  (84.5)  77  (75.5)  1  1
Outside of  Huambo  32  (15.5)  25  (24.5)  1.78  (0.98,  3.19)  0.056  1.3  (0.99,  1,29)  0.075
Sex
Male 130  (62.8) 73  (71.6) 1
Female  77  (37.2) 29  (28.4) 0.67  (0.40,  1.11) 0.128
Educational  qualifications
Illiterate  24  (11.6)  15  (14.7)  1
Primary  school  61  (29.5)  26  (25.5)  0.68  (0.31,  1.52)  0.343
Secondary  education  (1C) 55  (26.6)  34  (33.3)  0.99  (0.46,  2.17)  0.978
Secondary  education  (2C)  or  + 67  (32.4) 27  (26.5)  0.64  (0.29,  1.43)  0.273
Age
30 or  +  years 100  (48.3) 33  (32.4) 1  1
- than  30  years 107  (51.7) 69  (67.6)  1.95  (1.20,  3.24)  0.008* 1.22  (1.09,  1.35)  0.000*
Employment
Non  regular  occupation 172  (83.1) 83  (81.4) 1
Regular  occupation 35  (16.9) 19  (18.6) 1.12  (0.60,  2.07)  0.708
Consumption  of  alcoholic  beverages
Non-drinker  123  (59.4) 54  (52.9) 1
Current  drinker  33  (15.9)  26(25.5)  1.79  (0.98,  3.29)  0.058
Ex-drinker  51  (24.6)  22  (21.6)  0.98  (0.54,  1.77)  0.954
Smoking  tobacco
Non-smoker  173  (83.6)  73  (71.6)  1  1
Current smoker  16  (7.7)  18  (17.6)  2.67  (1.29,  5.57)  0.008* 1.31  (1.11,  1.55)  0.002*
Ex  smoker  18  (8.7)  11  (10.8)  1.45  (0.63,  3.18)  0.363  1.16  (0.97,  1.39)  0.113
Serology
Positive 16  (7.7)  10  (9.8)  1
Negative  191  (92.3)  92  (90.2)  0.77  (0.34,  1.82)  0.538
Family Support
Yes  161  (77.8)  66  (64.7)  1  1
No 46  (22.2)  36  (35.3)  1.91  (1.13,  3.22)  0.015* 1.13  (1.01,  1.27)  0.041*
* p < 0.05.
a  known  result  for  the  HIV  test  and  2  who  were  transferred
to  other  units
Overall  the  patients  included  had  a  median  age  of  26















Our  findings  show  that  being  younger  than  30  was  a  risk
factor  for  loss  to  follow-up.  Besides  that,  our  results  do  not
differ  much  from  studies  conducted  in  South  Africa4 and











An5  (82.5%)  had  non-regular  occupation,  177  (57.3%)  did  not
nsume  alcoholic  beverages,  246  (79.6%)  did  not  smoke
acco,  283  (91.6%)  had  negative  HIV  serology  and  227
.5%)  had  family  support  during  treatment  (Table  1).
Among  the  included  patients,  being  younger  than  30
ars  old  produced  a  2.69-fold  (95%  CI  1.56--4.78,  p  <  0.001)
rease  in  the  risk  of  being  lost  to  follow-up,  smoking
acco  resulted  in  a  3.54-fold  (95%  CI  1.61--7.99,  p  =  0.002)
her  risk.  Not  having  family  support  and  living  outside
ambo  city  were  both  associated  with  an  increased  risk
loss  to  follow-up  of  75%  (95%  CI  1.00--3.04,  p  =  0.047d  95%  CI  0.94--3.24,  p  =  0.078  respectively).  The  excluded
tients  differed  from  those  included  in  the  study  as  they





foopectively,  were  considered  protective  factors  for  loss  to
low-up.  As  for  what  life  is  like  in  Angola,  we  should  take
o  account  that  the  majority  of  the  population  is  extremely
ung,  since  65%  are  24  years  old  or  younger.6 One  possible
planation  for  this  is  the  socioeconomic  situation  in  Angola
ich  often  means  the  family  is  responsible  for  many  young
tients  and  also  leads  to  a  lack  of  access  to  transportation.
the  present  study,  it  was  observed  that  patients  without
ily  support  had  a  higher  risk  of  loss  to  follow-up,  and  this
s  also  observed  in  studies  conducted  in  South  Africa.7 In
gola  loss  to  follow-up  exceeded  10%.2 Based  on  our  study,
order  to  increase  adherence  of  TB  patients  to  treatment,
addition  to  the  DOTs  some  incentive  measures  should  be

































In  this  study  there  was  a  limitation  that  complete  trea
ment  cases  were  considered  as  successful  even  though  thes
could  not  be  classified  as  cured  because  there  was  no  micro
biological  evidence  at  the  end  of  treatment.
Based  on  the  results,  we  conclude  that  age,  lack  of  fami
support  and  smoking  tobacco  were  associated  with  loss  t
follow-up  in  TB  treatment  in  the  Huambo  province.
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